Erythropoiesis-stimulating agents should continue to have an oncology indication, even though questions about their safety remain. Medscape Medical News
Most current discovery strategies provide no clue as to whether proteins of interest are accessible, in human tissues, to suitable high-affinity ligands,such as systemically delivered MAbs. Expert Review of Proteomics
Consolidation treatment with radioactive yttrium-90 ibritumomab tiuxetan is feasible, well tolerated, and effective in untreated patients with follicular non-Hodgkin lymphoma. Medscape Medical News
Preoperative staging with PET/CT and cranial imaging was more precise in identifying patients with mediastinal and extrathoracic disease, preventing stage-inappropriate surgery in some patients. Medscape Medical News
Although lymphedema associated with breast cancer treatment is not currently curable, early detection, treatment, and maintenance contribute to better outcomes. Medscape Hematology-Oncology